Sugarcane molasses extract and its application in the preparation of drugs for chronic wound healing and its hydrogel
By using a simplified extraction and purification method for sugarcane molasses extract, combined with thermosensitive sustained-release hydrogel technology, the problem of difficult extraction of bioactive substances in existing technologies has been solved, resulting in the preparation of chronic wound healing drugs and dressings with multifunctionality and environmental advantages, which promote the rapid healing of chronic wounds.
Patent Information
- Application Number
- CN202410712238.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-06-04
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2044-06-04
AI Technical Summary
Existing technologies involve cumbersome extraction and purification processes for multifunctional bioactive substances, resulting in low levels of active ingredients and expensive raw materials, making them difficult to widely apply in chronic wound healing drugs, especially for the treatment of chronic diabetic wounds.
Sugarcane molasses extract was used to extract concentrated sugarcane molasses solution through ultrasonic treatment, filtration and rotary evaporation, macroporous resin adsorption and desorption. The solution was then combined with natural polysaccharide materials and grafted compounds to prepare thermosensitive sustained-release hydrogels loaded with sugarcane molasses extract for use in the preparation of chronic wound healing drugs and dressings.
The efficient extraction and purification of sugarcane molasses extract was achieved, and a thermosensitive sustained-release hydrogel with excellent biocompatibility, antioxidant, anti-inflammatory, antibacterial and angiogenesis-promoting capabilities was prepared to promote the rapid healing of chronic wounds. Moreover, the raw materials are widely available, inexpensive, and environmentally friendly.
Smart Images

Figure CN118717902B_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of medical polymer materials technology, and specifically relates to a sugarcane molasses extract and its application in the preparation of chronic wound healing drugs, as well as a thermosensitive sustained-release hydrogel based on the sugarcane molasses extract and its application, particularly the application of the hydrogel in the preparation of chronic wound healing drugs or dressings and tissue regeneration drugs or dressings. Background Technology
[0002] According to the International Diabetes Federation, diabetes is one of the most common diseases worldwide. Chronic hyperglycemia can lead to numerous complications, and many diabetic patients (approximately 30%) develop foot ulcers after trauma. These wounds are chronic and difficult to heal on their own, potentially leading to amputation in severe cases. Due to high morbidity, mortality, and significant healthcare costs, chronic diabetic wounds have become a global public health issue. Unlike acute wounds, chronic diabetic wounds typically involve a persistent inflammatory phase and a complex wound microenvironment, which may be attributed to a combination of factors, including hyperglycemia, oxidative stress, difficulty in angiogenesis, and impaired vascular function. Furthermore, this microenvironment makes diabetic wounds more susceptible to bacterial infection than other types of wounds, often leading to exacerbated inflammation and deeper tissue damage, thus making chronic diabetic wounds even more difficult to heal. The mechanisms underlying poor healing of similar chronic wounds are not yet fully understood.
[0003] Research on wound dressings for various types of external chronic trauma is increasing. Wound dressings are materials that cover the wound, protect tissue from secondary damage, prevent bleeding and bacterial infection, effectively deliver wound-healing medications, and promote wound healing; they are an important treatment method for wound management. It is worth noting that complex pathological chronic wounds often require wound dressings with multiple properties; and introducing multifunctional bioactive substances into dressings can accelerate wound healing by regulating the local wound microenvironment. Therefore, developing a dressing material with multifunctional bioactive substances is crucial for the healing of chronic wounds.
[0004] Currently, domestic and international research is paying increasing attention to the value of natural plants and the availability of their extracts as wound healing drugs. Research on the development and application of active substances in plants is also becoming more in-depth, and active substances that can promote skin wound healing have been discovered and extracted from many plant extracts. These active substances usually have multiple pharmacological functions.
[0005] However, most multifunctional bioactive substances currently suffer from problems such as overly complicated extraction and purification steps, low content of effective components, and expensive sources of raw materials, making them difficult to use widely in practical applications.
[0006] Therefore, there is an urgent need to find natural and inexpensive plant sources and efficient extraction methods for multifunctional bioactive substances, and to construct a type of hydrogel dressing that uses active substances from natural and inexpensive plant sources for continuous drug delivery, providing a new approach to wound healing in chronic diabetes. Summary of the Invention
[0007] In order to overcome the shortcomings and deficiencies of the prior art, the primary objective of this invention is to provide a sugarcane molasses extract.
[0008] Another objective of this invention is to provide the application of sugarcane molasses extract in the preparation of a chronic wound healing drug.
[0009] Another objective of this invention is to provide a thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract.
[0010] The thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract of the present invention has excellent biocompatibility, antioxidant, anti-inflammatory, antibacterial, angiogenesis-promoting, and glycemic index-lowering abilities. Through long-term release at the wound site, it enhances cell vitality and promotes cell proliferation from multiple aspects and at a deep level, thereby promoting wound healing and achieving the goal of rapid wound healing. It can be applied to the preparation of chronic wound healing drugs or dressings and tissue regeneration drugs or dressings.
[0011] Another objective of this invention is to provide a method for preparing the above-mentioned thermosensitive sustained-release hydrogel.
[0012] Another object of the present invention is to provide the application of the above-mentioned thermosensitive sustained-release hydrogel.
[0013] The objective of this invention is achieved through the following solution:
[0014] In a first aspect, the present invention provides a sugarcane molasses extract.
[0015] In the technical solution of this invention, the sugarcane molasses extract can be prepared by the following method: mixing sugarcane molasses liquid with ethanol solution, ultrasonic treatment, filtration and rotary evaporation to obtain sugarcane molasses concentrate; and separating the sugarcane molasses extract by adsorption and desorption through macroporous resin.
[0016] Furthermore, the sugarcane molasses solution is obtained by adding sugarcane molasses to water. The concentration can be 10-40 wt%.
[0017] Furthermore, the volume ratio of the sugarcane molasses solution to the ethanol solution can be 1:1 to 1:3.
[0018] Furthermore, the concentration of the ethanol solution can be 30-80%.
[0019] Furthermore, the duration of the ultrasonic treatment can be 0.5-2 hours.
[0020] Furthermore, the ultrasonic treatment can be performed at 50-60°C.
[0021] Furthermore, the power of the ultrasonic treatment can be 100-500W.
[0022] Further, the sugarcane molasses is obtained by filtration and rotary evaporation. Rotary evaporation concentration can be carried out at 50-60℃.
[0023] Furthermore, the volume ratio of the macroporous resin to the concentrated sugarcane molasses solution can be 1:1 to 1:5.
[0024] Furthermore, the macroporous resin may be NKA-II macroporous resin. The macroporous resin may undergo pre-activation treatment before use.
[0025] Furthermore, the adsorption via macroporous resin can be achieved by mixing macroporous resin with concentrated sugarcane molasses solution for adsorption, or by passing the concentrated sugarcane molasses solution through a column loaded with macroporous resin for adsorption.
[0026] When the mixture is used for adsorption, the adsorption time can be 0.5-5 hours. Stirring can be performed during adsorption to make the mixture more uniform and better for adsorption. After adsorption, it can be filtered to obtain macroporous resin with adsorbed sugarcane molasses extract.
[0027] When adsorption occurs through the column, the concentrated sugarcane molasses solution can circulate through the resin in the column to make the adsorption more complete; preferably twice or more.
[0028] Furthermore, the macroporous resin can be rinsed with water before desorption, until it becomes colorless.
[0029] Furthermore, desorption can be carried out using an ethanol solution. The concentration of the ethanol solution used can be 30-80%.
[0030] Furthermore, desorption can be carried out by immersing the macroporous resin in an ethanol solution or by passing it through a column in an ethanol solution.
[0031] When using immersion desorption, the immersion time can be 1-10 hours. Stirring during immersion can ensure more thorough elution. After immersion, the eluent can be obtained using conventional methods such as filtration.
[0032] When desorbing through the column, the ethanol solution should be added slowly, and the mixing time between the ethanol solution and the resin should be greater than or equal to 2 minutes to ensure better elution effect.
[0033] Furthermore, the eluent obtained after elution can be filtered through a 0.22-0.45 μm filter membrane and then concentrated by rotary evaporation at 50-60℃ and freeze-dried to obtain sugarcane molasses extract.
[0034] Before using the above method, the sugarcane molasses solution can be crudely purified. The purification process involves first adjusting the pH of the sugarcane molasses solution to acidic (e.g., pH=2, which can be adjusted by adding sulfuric acid solution, such as 18 mol / L sulfuric acid solution), then heating (e.g., heating at 70-90℃ for 30-120 min), and after cooling, adding phosphoric acid solution (phosphoric acid solution is used to adjust the pH of the system to cause heavy metal ions to precipitate and separate; the amount used is 0.1-0.5% of the total system volume). Then, adding alkali to neutralize the pH (e.g., adjusting to pH 7 with saturated calcium hydroxide solution), and then adding polyacrylamide (polyacrylamide is used for flocculation; the amount used is 0.05-3 g / L solution) and stirring evenly. The solution is then heated again (e.g., adding at 70-90℃ for 5-30 min) to cause colloidal flocculation and precipitation. After standing and cooling, the colloidal flocculation is removed, yielding the crudely purified sugarcane molasses solution. Furthermore, the removal of colloidal flocs can be achieved through centrifugation (e.g., centrifuging at 5000g for 15 minutes), filtration, or other methods.
[0035] The sugarcane molasses extract of this invention is a brownish-brown powder rich in multifunctional bioactive substances, including polyphenolic compounds, various glycosides, unsaturated fatty acids, etc. It has excellent biocompatibility, antioxidant, anti-inflammatory, antibacterial, free radical scavenging, angiogenesis promotion, and glycemic index reduction capabilities. When applied to the preparation of chronic wound healing drugs, this invention can achieve the purpose of promoting wound healing.
[0036] Secondly, the present invention provides the application of sugarcane molasses extract in the preparation of drugs for chronic wound healing, medical dressings for promoting chronic and difficult-to-heal wounds, and drugs or dressings for tissue regeneration.
[0037] In the technical solution of this invention, the drugs, whether the same or different, include a therapeutically effective amount of sugarcane molasses extract.
[0038] In the technical solution of this invention, the same or different drugs can be made into various pharmaceutical dosage forms using conventional methods. These dosage forms include: tablets, sugar-coated tablets, film-coated tablets, enteric-coated tablets, capsules, hard capsules, soft capsules, oral liquids, lozenges, granules, powders, pills, elixirs, suspensions, tinctures, drops, and other oral dosage forms, as well as non-oral dosage forms such as injections.
[0039] In the technical solution of the present invention, the drugs, whether the same or different, may also contain one or more pharmaceutically acceptable carriers or excipients.
[0040] Furthermore, the excipients may include diluents, wetting agents, lubricants, fillers, preservatives, etc.
[0041] Thirdly, the present invention provides a thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract, which is obtained by combining sugarcane molasses extract, natural polysaccharide materials, and water.
[0042] Fourthly, a thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract is specifically prepared from the following raw materials: sugarcane molasses extract, grafting compound, oxidant, activator, natural polysaccharide material and water.
[0043] In the hydrogel of this invention, the content of sugarcane molasses extract can be 0.1-10 mg / mL.
[0044] In the hydrogel of this invention, the natural polysaccharide material may include at least one of sodium alginate, hyaluronic acid, chitosan, collagen, gelatin, cellulose, etc.
[0045] Furthermore, the natural polysaccharide material may include at least two of the following: sodium alginate, hyaluronic acid, chitosan, collagen, gelatin, and cellulose.
[0046] Furthermore, the natural polysaccharide material may include sodium alginate and gelatin, respectively.
[0047] Furthermore, the amount of natural polysaccharide material used is the same as that used in the conventional preparation of hydrogels, such as 10-50 wt%.
[0048] In the hydrogel of this invention, the oxidant can be sodium periodate, chromic acid and its salts (such as potassium dichromate, K2Cr2O7), potassium permanganate, hydrogen peroxide, peracetic acid, etc., and its molar ratio with the natural polysaccharide material is preferably 1:0.5-1:5.
[0049] In the hydrogel of the present invention, the grafting compound may include at least one of dopamine hydrochloride, dopamine, norepinephrine, etc.
[0050] Furthermore, the preferred molar ratio of the grafted compound to the natural polysaccharide material is 1:1 to 1:10.
[0051] In the hydrogel of this invention, the activator may be EDC / NHS (N-hydroxysuccinimide / 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride), triphenylphosphine / diethyl azodicarboxylate (TPP / DEAD), or 4-dimethylaminopyridine (DMAP).
[0052] Furthermore, the molar ratio of the activator to the natural polysaccharide material is preferably 1:1 to 1:4.
[0053] Fifthly, the present invention also provides a method for preparing the above-mentioned thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract. Specifically, the method involves first oxidizing a portion of the natural polysaccharide material using an oxidizing agent, and then reacting the oxidized natural polysaccharide material with a grafting compound under the action of an activator to obtain a grafted modified natural polysaccharide material. Finally, the remaining natural polysaccharide material, the grafted modified natural polysaccharide material, and the sugarcane molasses extract are mixed in water and crosslinked to obtain the hydrogel.
[0054] In the above preparation method, the oxidation of some natural polysaccharide materials by oxidizing the oxidant can be achieved by mixing the oxidant and some natural polysaccharide materials in water, terminating the oxidation reaction with a terminator, and then separating the oxidized natural polysaccharide materials.
[0055] Furthermore, some natural polysaccharide materials can account for 10-100% of the total mass of natural polysaccharide materials.
[0056] Furthermore, the concentration of some natural polysaccharide materials in the oxidation reaction system can be 0.5-2% (w / v).
[0057] Furthermore, the molar ratio of the natural polysaccharide material and the oxidant used can be 0.5:1 to 5:1.
[0058] Furthermore, the oxidation reaction can take 9-10 hours.
[0059] Furthermore, conventional terminators such as ethylene glycol or methanol can be used. The amount of terminator used is the conventional amount, such as a molar ratio of terminator to some natural polysaccharide material of 1:1 to 3:1.
[0060] Furthermore, the separation can be achieved through conventional methods such as dialysis and freeze-drying.
[0061] Furthermore, dialysis should continue until the dialysate is neutral.
[0062] In the above preparation method, the grafting reaction is carried out in water. Specifically, the oxidized natural polysaccharide material, activator, and grafting compound are added to water and stirred to react.
[0063] Furthermore, the grafting reaction is preferably carried out in a closed system under the protection of an inert gas.
[0064] Furthermore, the grafting reaction time can be 1-24 hours.
[0065] Furthermore, the pH of the grafting reaction system is preferably weakly acidic, ideally between 4 and 5. The pH can be adjusted using common acidic reagents such as hydrochloric acid (e.g., 1M hydrochloric acid).
[0066] Furthermore, after the grafting reaction is completed, the grafted modified natural polysaccharide material can be separated by conventional methods such as dialysis and freeze-drying. The dialysis is preferably performed in a weakly acidic environment.
[0067] In the above preparation method, the hydrogel obtained by the reaction refers to the process of mixing the components evenly through conventional operations, such as heating and then cooling to form a gel.
[0068] Furthermore, the heating temperature can be 30-55℃.
[0069] Furthermore, the gel can be cooled at 4°C for 1-4 hours.
[0070] In the above preparation method, the remaining natural polysaccharide material, grafted modified natural polysaccharide material, and sugarcane molasses extract are mixed in water and crosslinked to obtain a hydrogel. Specifically, the remaining natural polysaccharide material can be added to water and heated to dissolve before adding the grafted modified natural polysaccharide material and sugarcane molasses extract and mixing evenly. Then, the mixture is cooled and allowed to stand to form a gel.
[0071] Furthermore, the heating temperature can be 30-55°C.
[0072] The thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract of the present invention forms a stable hydrogel by uniformly mixing the components and cross-linking the natural polysaccharide material. The cross-linking mechanism of the natural polysaccharide material may include anionic and cationic cross-linking, cross-linking of intertwined polymer chains, crystallization cross-linking, covalent cross-linking, hydrogen bonding cross-linking, or a combination of the above mechanisms.
[0073] The thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract of this invention contains sugarcane molasses extract with excellent biocompatibility, antioxidant, anti-inflammatory, antibacterial, free radical scavenging, angiogenesis-promoting, and glycemic index-lowering abilities. Combined with the grafted modified natural polysaccharide material of this invention, the resulting hydrogel is natural, mild, and highly effective, and can be released for a long time at the wound site to promote wound healing. It can be used in the preparation of chronic wound healing drugs. Compared with existing multifunctional bioactive substances, the sugarcane molasses extract of this invention has simple and easy extraction and purification steps. The sugarcane molasses raw material of this invention is a byproduct of refined sugar production in the sugarcane sugar industry, which has the advantages of wide availability and low price. The recycling of sugarcane molasses can also achieve the goal of green and environmental protection; at the same time, no toxic byproducts are generated during the preparation of the sugarcane molasses extract. The thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract of the present invention has good biocompatibility and has antibacterial, antioxidant, free radical scavenging, and anti-inflammatory effects without increasing cytotoxicity. It has significant advantages in the application of hydrogel in the biomedical field, such as in the preparation of tissue engineering materials, such as hydrogel dressings, especially in the preparation of medical dressings that promote chronic and difficult-to-heal wounds, and in the preparation of tissue regeneration drugs or dressings.
[0074] Compared with the prior art, the present invention has the following beneficial effects:
[0075] (1) The sugarcane molasses extract of the present invention has the advantages of wide availability and low price compared with the existing sources of raw materials for the extraction of multifunctional bioactive substances. The recycling of sugarcane molasses can also achieve the purpose of green and environmental protection.
[0076] (2) The sugarcane molasses extract of the present invention has excellent biocompatibility, antioxidant, anti-inflammatory, antibacterial, angiogenesis-promoting and glycemic index-lowering abilities.
[0077] (3) This invention introduces sugarcane molasses extract into the field of tissue repair for the first time. Based on this, the thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract is made of natural ingredients, is easy to manufacture, and has excellent biocompatibility.
[0078] (4) The thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract of the present invention can be used to prepare dressings, which can effectively take into account biocompatibility, anti-oxidation, anti-inflammation, antibacterial, angiogenesis promotion and glycemic index reduction, improve cell vitality and promote cell proliferation from multiple aspects and at a deep level, and achieve the purpose of rapid wound healing. Attached Figure Description
[0079] To more clearly illustrate the technical solutions of the embodiments of the present invention, the accompanying drawings used in the embodiments will be briefly introduced below. It should be understood that the following drawings only show some embodiments of the present invention and should not be regarded as a limitation on the scope. For those skilled in the art, other related drawings can be obtained based on these drawings without creative effort.
[0080] Figure 1 This is a sugarcane molasses extract powder sample.
[0081] Figure 2 This is the UV-Vis spectrum of a sugarcane molasses extract solution.
[0082] Figure 3 A quantitative standard curve for total polyphenols from sugarcane molasses extract.
[0083] Figure 4 This is the total ion chromatogram in negative ion mode for sugarcane molasses extract.
[0084] Figure 5 This is a statistical graph showing the effect of sugarcane molasses extract on the cell viability of HUVECs.
[0085] Figure 6 Images showing the live / dead staining of HUVECs by sugarcane molasses extract.
[0086] Figure 7 Fluorescence images of sugarcane molasses extract co-cultured with HUVECs.
[0087] Figure 8 This is a statistical graph showing the cell viability of HUVECs on hydrogels.
[0088] Figure 9 Images showing the live / dead staining of HUVECs by hydrogel.
[0089] Figure 10 The release curve of the hydrogel in PBS is shown.
[0090] Figure 11 The temperature dependence of the storage modulus (G') and loss modulus (G”) of the hydrogel.
[0091] Figure 12 The value represents the scavenging rate of the hydrogel against DPPH free radicals.
[0092] Figure 13 The scavenging rate of the hydrogel against ABTS free radicals is denoted as .
[0093] Figure 14 The image shows the fluorescence of the hydrogel after co-culturing with HUVECs.
[0094] Figure 15 The antibacterial curves of the hydrogel against Escherichia coli (A) and Staphylococcus aureus (B) are shown.
[0095] Figure 16 This image shows the wound healing effect in a rat experiment. Detailed Implementation
[0096] The present invention will be further described in detail below with reference to embodiments, but the implementation of the present invention is not limited thereto. Unless otherwise specified, all materials involved in the following embodiments are commercially available. Unless otherwise specified, all methods described are conventional methods. Sugarcane molasses raw material can be purchased.
[0097] One embodiment provides a sugarcane molasses extract.
[0098] In a specific embodiment of the present invention, sugarcane molasses extract can be prepared by the following method: mixing sugarcane molasses liquid with ethanol solution, ultrasonic treatment, filtering and rotary evaporation to obtain sugarcane molasses concentrate; and separating the sugarcane molasses extract by adsorption and desorption through macroporous resin.
[0099] In a specific embodiment of the present invention, the sugarcane molasses solution is obtained by adding sugarcane molasses to water, and the concentration can be 10-40 wt%. In one embodiment, the concentration is 10 wt%; in another embodiment, the concentration is 16 wt%; and in yet another embodiment, the concentration is 25 wt%.
[0100] In a specific embodiment of the present invention, the volume ratio of the sugarcane molasses solution to the ethanol solution can be 1:1 to 1:3. In one embodiment, the volume ratio is 1:1; in another embodiment, the volume ratio is 1:2; and in yet another embodiment, the volume ratio is 1:3.
[0101] In a specific embodiment of the present invention, the concentration of the ethanol solution is 30-80%. For example, the concentration of the ethanol solution can be 75%.
[0102] In a specific embodiment of the present invention, the ultrasonic treatment time can be 0.5-2 hours; for example, 1 hour.
[0103] In a specific embodiment of the present invention, the ultrasonic treatment can be performed at 50-60°C, such as 56°C.
[0104] In a specific embodiment of the present invention, the power of the ultrasonic treatment can be 100-500W, such as 300W.
[0105] In a specific embodiment of the present invention, sugarcane molasses concentrate is obtained by filtration and rotary evaporation. Rotary evaporation concentration can be carried out at 50-60°C (e.g., 56°C).
[0106] In a specific embodiment of the present invention, the volume ratio of the macroporous resin to the concentrated sugarcane molasses solution can be 1:1 to 1:5; in one embodiment, the volume ratio is 1:1; in another embodiment, the volume ratio is 1:2.5.
[0107] In a specific embodiment of the present invention, the macroporous resin may be NKA-II macroporous resin. The macroporous resin may undergo pre-activation treatment before use.
[0108] In a specific embodiment of the present invention, the adsorption via macroporous resin can be performed by mixing macroporous resin with sugarcane molasses concentrate for adsorption, or by passing sugarcane molasses concentrate through a column loaded with macroporous resin for adsorption.
[0109] In one embodiment, the mixture is mixed for adsorption, and the adsorption time is 0.5-5 hours (e.g., 1.5 hours). During adsorption, the mixture can be stirred to make it more uniform and better for adsorption. After adsorption, the mixture is filtered to obtain a macroporous resin adsorbed with sugarcane molasses extract.
[0110] In another embodiment, adsorption is performed by passing the sugarcane molasses concentrate through a column, with the concentrate circulating through the resin in the column two or more times to ensure more complete adsorption.
[0111] In a specific embodiment of the present invention, the macroporous resin can be rinsed with water before desorption, and the rinsing can be carried out until it is colorless before desorption.
[0112] In a specific embodiment of the present invention, desorption can be carried out using an ethanol solution. The concentration of the ethanol solution used can be 30-80% (e.g., 75%).
[0113] In a specific embodiment of the present invention, desorption can be carried out by immersing the macroporous resin in an ethanol solution or by passing it through a column with an ethanol solution.
[0114] In one embodiment, the soaking time for desorption can be 1-10 hours (e.g., 3 hours). Stirring during soaking can ensure more thorough elution. After soaking, the eluent can be obtained using conventional methods such as filtration.
[0115] In another embodiment, during column desorption, the ethanol solution is added slowly, and the mixing time between the ethanol solution and the resin is greater than or equal to 2 minutes to ensure better elution effect.
[0116] In a specific embodiment of the present invention, the eluent obtained after elution can be filtered through a 0.22-0.45μm (e.g., 0.45μm) filter membrane and then concentrated by rotary evaporation at 50-60℃ and freeze-dried to obtain sugarcane molasses extract.
[0117] The sugarcane molasses solution used in the above method can be crudely purified before use. The purification process involves first adjusting the pH of the sugarcane molasses solution to acidic (e.g., pH=2, which can be adjusted by adding sulfuric acid solution, such as 18 mol / L sulfuric acid solution), then heating (e.g., heating at 70-90℃ for 30-120 min), and after cooling, adding phosphoric acid solution (0.1-0.5% of the total system volume), then neutralizing the pH with alkali (e.g., adjusting to pH 7 with saturated calcium hydroxide solution), and finally adding polyacrylamide (0.05-3 g / L solution) and stirring evenly. The solution is then heated again (e.g., adding at 70-90℃ for 5-30 min) to cause colloidal flocculation and precipitation. After standing and cooling, the colloidal flocculation is removed, yielding crudely purified sugarcane molasses solution. Further, the removal of colloidal flocculation can be achieved through centrifugation (e.g., centrifuging at 5000g for 15 min), filtration, etc.
[0118] The sugarcane molasses extract used in the embodiments of this invention can be prepared by the following specific methods:
[0119] Sugarcane molasses solution (10-40 wt%) and ethanol solution (30-80%) were mixed evenly at a volume ratio of 1:1-1:3 and subjected to ultrasonic-assisted extraction at 50-60℃ and 100-500W for 0.5-2 hours. The mixture was then vacuum filtered and rotary evaporated in a water bath at 50-60℃ to obtain a concentrated solution. The concentrated sugarcane molasses solution was mixed with pre-activated NKA-II macroporous resin at a volume ratio of 1:1-1:5 and stirred for adsorption for 0.5-5 hours. The mixture was filtered, and the macroporous resin was washed with water until colorless. Then, ethanol solution (30-80%) was added to soak the macroporous resin for desorption for 1-10 hours. The mixture was filtered, rotary evaporated in a water bath at 50-60℃, and freeze-dried to obtain the sugarcane molasses extract.
[0120] The above-mentioned sugarcane molasses solution is obtained by adding sugarcane molasses to water, and preferably undergoes crude extraction before mixing with ethanol solution. Sulfuric acid solution is added dropwise to adjust the pH to acidic (pH approximately 2), and the solution is heated at 70-90℃ for 30-120 min. After cooling, 0.1-0.5% phosphoric acid solution (total volume) is added, followed by neutralization with saturated calcium hydroxide solution (pH approximately 7). Then, 0.05-3 g / L of polyacrylamide solution is added and stirred evenly. The solution is heated again at 70-90℃ for 5-30 min to induce colloidal flocculation and precipitation. After cooling and standing, the solution is centrifuged (5000 g, 15 min) and filtered to remove colloidal flocculation, yielding crudely purified sugarcane molasses solution.
[0121] The sugarcane molasses extract of this invention is a brownish-brown powder, such as... Figure 1 As shown, when stored in a sealed, light-proof container at -18°C, 289 parts by weight of sugarcane molasses raw material can yield 9.97 parts by weight of sugarcane molasses extract, with a yield of 3.45%.
[0122] In one embodiment, a 0.1 mg / mL sugarcane molasses extract solution was prepared using deionized water, and its UV-Vis spectrum was measured. The absorption spectrum is shown below. Figure 2 As shown, its maximum absorption peak appears at 290 nm, A(290 nm) = 0.91354.
[0123] One embodiment is the application of sugarcane molasses extract in the preparation of drugs for chronic wound healing, medical dressings for promoting chronic, difficult-to-heal wounds, and drugs or dressings for tissue regeneration.
[0124] One embodiment is a thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract, which is obtained by combining sugarcane molasses extract, natural polysaccharide materials, and water.
[0125] One embodiment is a thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract, specifically prepared from the following raw materials: sugarcane molasses extract, grafting compound, oxidant, activator, natural polysaccharide material and water.
[0126] In a specific embodiment of the present invention, the content of sugarcane molasses extract is 0.1-10 mg / mL.
[0127] In a specific embodiment of the present invention, the natural polysaccharide material may include at least one of sodium alginate, hyaluronic acid, chitosan, collagen, gelatin, cellulose, etc.
[0128] In specific embodiments of the present invention, the natural polysaccharide material includes at least two of sodium alginate, hyaluronic acid, chitosan, collagen, gelatin, and cellulose. In one embodiment, the natural polysaccharide material includes sodium alginate and gelatin.
[0129] In a specific embodiment of the present invention, the amount of natural polysaccharide material used is the same as that used in the conventional preparation of hydrogels, such as 10-50 wt%.
[0130] In a specific embodiment of the present invention, the oxidant may be sodium periodate, chromic acid and its salts (such as potassium dichromate, K2Cr2O7), potassium permanganate, hydrogen peroxide, peracetic acid, etc., and its amount is preferably in a molar ratio of 1:0.5-1:5 with that of the natural polysaccharide material.
[0131] In a specific embodiment of the present invention, the grafting compound may include at least one of dopamine hydrochloride, dopamine, norepinephrine, etc.
[0132] In a specific embodiment of the present invention, the amount of the grafting compound is preferably in a molar ratio of 1:1 to 1:10 with the natural polysaccharide material.
[0133] In a specific embodiment of the present invention, the activator may be EDC / NHS (N-hydroxysuccinimide / 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride), triphenylphosphine / diethyl azodicarboxylate (TPP / DEAD), or 4-dimethylaminopyridine (DMAP).
[0134] In a specific embodiment of the present invention, the molar ratio of the activator to the natural polysaccharide material is preferably 1:1 to 1:4.
[0135] In another embodiment, the present invention also provides a method for preparing the above-mentioned thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract. Specifically, a portion of the natural polysaccharide material is first oxidized using an oxidant, and the oxidized natural polysaccharide material is reacted with a grafting compound under the action of an activator to obtain a grafted modified natural polysaccharide material. Finally, the remaining natural polysaccharide material, the grafted modified natural polysaccharide material, and the sugarcane molasses extract are mixed in water and crosslinked to obtain a hydrogel.
[0136] In a specific embodiment of the present invention, the oxidation of a portion of the natural polysaccharide material by using an oxidant can be achieved by mixing the oxidant and the portion of the natural polysaccharide material in water, reacting them, terminating the oxidation reaction with a terminator, and then separating the oxidized natural polysaccharide material.
[0137] In a specific embodiment of the present invention, a portion of the natural polysaccharide material may account for 10-100% of the total mass of the natural polysaccharide material.
[0138] In a specific embodiment of the present invention, the concentration of some natural polysaccharide materials in the oxidation reaction system can be 0.5-2% (w / v).
[0139] In a specific embodiment of the present invention, the molar ratio of the natural polysaccharide material and the oxidant used can be 0.5:1-5:1.
[0140] In a specific embodiment of the present invention, the oxidation reaction time can be 9-10 hours.
[0141] In a specific embodiment of the present invention, a conventional terminator, such as ethylene glycol or methanol, can be used. The amount of terminator used is the conventional amount, such as a molar ratio of terminator to part of the natural polysaccharide material of 1:1 to 3:1.
[0142] In a specific embodiment of the present invention, the separation can be performed by conventional methods such as dialysis or freeze-drying.
[0143] In a specific embodiment of the present invention, dialysis is performed until the dialysate is neutral.
[0144] In a specific embodiment of the present invention, the grafting reaction can be carried out in water. Specifically, oxidized natural polysaccharide material, activator, and grafting compound can be added to water and stirred to react.
[0145] In a specific embodiment of the present invention, the grafting reaction is preferably carried out in a closed system under the protection of an inert gas.
[0146] In a specific embodiment of the present invention, the grafting reaction time can be 1-24 hours.
[0147] In a specific embodiment of the present invention, the pH of the grafting reaction system is preferably weakly acidic. A pH of 4-5 is preferred. The pH can be adjusted using conventional acidic reagents such as hydrochloric acid (e.g., 1M hydrochloric acid).
[0148] In a specific embodiment of the present invention, after the grafting reaction is completed, the grafted modified natural polysaccharide material can be separated by conventional methods such as dialysis and freeze-drying. The dialysis is preferably performed in a weakly acidic environment.
[0149] In a specific embodiment of the present invention, the reaction to obtain a hydrogel refers to the process of mixing the components uniformly by conventional operations, such as heating and then cooling to form a gel.
[0150] In a specific embodiment of the present invention, the heating temperature can be 30-55°C.
[0151] In a specific embodiment of the present invention, the gel can be cooled at 4°C for 1-4 hours.
[0152] In a specific embodiment of the present invention, the remaining natural polysaccharide material, the grafted modified natural polysaccharide material, and the sugarcane molasses extract are mixed in water and crosslinked to obtain a hydrogel. Specifically, the remaining natural polysaccharide material can be added to water and heated to dissolve before adding the grafted modified natural polysaccharide material and the sugarcane molasses extract and mixing evenly, and then cooled and allowed to stand to form a gel.
[0153] In a specific embodiment of the present invention, the heating temperature can be 30-55°C.
[0154] The thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract of the present invention forms a stable hydrogel by uniformly mixing the components and cross-linking the natural polysaccharide material. The cross-linking mechanism of the natural polysaccharide material may include anionic and cationic cross-linking, cross-linking of intertwined polymer chains, crystallization cross-linking, covalent cross-linking, hydrogen bonding cross-linking, or a combination of the above mechanisms.
[0155] Example 1: Component testing and in vitro cell biological evaluation of sugarcane molasses extract
[0156] For ease of comparison, the sugarcane molasses extracts in the following examples were all prepared from the same batch of sugarcane molasses raw materials.
[0157] The total phenol content in sugarcane molasses extract was determined using the Folin-Ciocalteu method. Gallic acid was used as the standard solution, and a standard curve was plotted. Figure 3 As shown, the absorbance of the sample reaction solution was measured at a wavelength of 763 nm. The total phenolic content in the sample was calculated based on the gallic acid standard curve and expressed as milligram gallic acid equivalents (GAE) per 100 grams of sample, i.e., mg GAE / 100g. Calculations showed that the total polyphenol content in the obtained sugarcane molasses extract was 21.8%, or 21800 mg GAE / 100g.
[0158] The components of sugarcane molasses extract were analyzed using LC-MS / MS (Agilent 1100; API4000 triple quadrupole mass spectrometer). Considering the complex composition of sugarcane molasses extract and the limitations of detection methods and polyphenol standards, 10 polyphenol standards (numbered S01-S10) were selected for quantitative analysis of the sugarcane molasses extract.
[0159] Sugarcane molasses extract was dissolved and diluted to 1 mg / mL with 75% methanol and filtered through a 0.22 μm filter membrane before analysis. The preferred chromatographic column was an Agilent Poroshell 120EC-C18 2.7 μm (3 mm × 50 mm). Mobile phase A: 0.5% formic acid in water; Mobile phase B: acetonitrile solution; Flow rate: 0.6 mL / min; Injection volume: 10 μL; Column temperature: 35℃; Multiple reaction monitoring (MRM) detection conditions: spray voltage 4.5-5.5 kV; desolvation temperature 500℃; desolvation gas (N2) 1000 L / h. Mass spectrometry scanning conditions: ESI+ mode: spray voltage 5.5 kV; desolvation temperature 500℃; desolvation gas (N2) 1000 L / h; ESI- mode: spray voltage 4.5 kV; desolvation temperature 500℃; desolvation gas (N2) 1000 L / h. The gradient elution program is shown in Table 1 below.
[0160] Table 1
[0161]
[0162] The analysis results are shown in Table 2 (numbered S01-S10). Figure 4 (As shown in the numbers S01-S10). The results show that among the 10 polyphenols analyzed quantitatively, syringic acid, rosmarinic acid, and p-coumaric acid were the most abundant.
[0163] The LC-MS / MS system and liquid chromatography parameters were as described above, with the mass spectrometry scan range set to: 80-2000 m / z (Level 1); ESI mode: spray voltage 3.2 kV; desolventizing temperature 350℃; desolventizing gas (N2) 720 L / h. Qualitative analysis was performed on the sugarcane molasses extract, and the analytical results were matched with chemical substances in the traditional Chinese medicine database. The output results are shown in Table 3 (numbered 11-25). Figure 4 The 15 chemical substances shown (numbered 11-25) indicate that the sugarcane molasses extract also contains a large amount of glycosides and unsaturated fatty acids.
[0164] Table 2
[0165]
[0166] Table 3
[0167]
[0168] Five different sugarcane molasses extract concentrations were obtained by adjusting the sugarcane molasses extract content in the cell culture medium: 0.1 mg / mL, 0.5 mg / mL, 1 mg / mL, 1.5 mg / mL, and 2 mg / mL. A control group without added sugarcane molasses extract was also included. All six cell cultures were co-cultured with human umbilical vein endothelial cells (HUVECs) at 37°C in a 5% CO2 incubator. Cell proliferation was assessed using a CCK-8 assay on days 1, 3, and 5. The experimental groups were treated similarly. Morphological analysis of dead and living cells was performed, and fluorescence images of live and dead cells were captured. The results are shown below. Figure 5 and Figure 6 As shown.
[0169] Depend on Figure 5 The cell viability statistics show that when the sugarcane molasses extract content in the culture medium reaches 1 mg / mL, the cell viability still reaches 86.58% after 5 days of co-culture, indicating that the sugarcane molasses extract of the present invention has almost no cytotoxicity at low concentrations; however, when the sugarcane molasses extract content in the culture medium is 1.5 mg / mL or higher, the cell viability decreases significantly after 5 days of co-culture, indicating that excessively high concentrations of sugarcane molasses extract will exhibit toxic side effects on cells. Figure 6 Live / dead staining images showed that most HUVECs in the experimental groups that had been treated with sugarcane molasses extract exhibited normal morphology.
[0170] The ability of serum-free culture media containing 1 mg / mL and 2 mg / mL of sugarcane molasses extract to scavenge reactive oxygen species in human umbilical vein endothelial cells was evaluated using the DCFH-DA kit. DCFH-DA (green) and DAPI (blue) staining were performed, and the results are shown below. Figure 7 As shown, the green fluorescence intensity darkened after adding serum-free culture medium containing a certain concentration of sugarcane molasses extract. Specifically, concentrations of 1 mg / mL and 2 mg / mL of sugarcane molasses extract significantly reduced the green fluorescence intensity, bringing it close to that of the negative control group without hydrogen peroxide stimulation. These results indicate that sugarcane molasses extract has the ability to significantly reduce intracellular reactive oxygen species (ROS) levels, protecting cells from excessive ROS damage and effectively promoting wound healing.
[0171] Example 2: Preparation and in vitro cell compatibility test of thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract.
[0172] Sodium alginate (SA) was dissolved at a mass-volume ratio of 1% and mixed with sodium periodate at a molar ratio of 1:1 for 9-10 hours. The reaction was terminated with ethylene glycol. The solution after the oxidation reaction was terminated was dialyzed under a neutral environment for 72 hours and then freeze-dried to obtain oxidized alginate (OSA).
[0173] The mixture was blended according to the ratio of n(oxidized alginate):n(N-hydroxysuccinimide):n(1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride):n(dopamine or dopamine hydrochloride) = 2:2:2:1. The pH of the reaction solution was adjusted to 4.5-4.7. The mixture was sealed and stirred under nitrogen protection for 12 hours. The resulting solution was dialyzed under a weakly acidic environment for 72 hours and then freeze-dried to obtain dopamine-grafted oxidized alginate (OSA-DA).
[0174] Gelatin was added to deionized water and heated and stirred at 45°C for 1 hour to obtain a 20% (w / v) gelatin solution. While continuously heating and stirring at 45°C, dopamine-grafted oxidized alginate (OSA-DA) was added to the gelatin solution at a mass-volume ratio of 20%, along with a certain amount of sugarcane molasses extract powder. After stirring until homogeneous, the solution was injected into a mold using a syringe and allowed to stand in a refrigerator at 4°C for 1-2 hours to form a gel.
[0175] The content of sugarcane molasses extract in the above hydrogels was adjusted to obtain five hydrogels with different sugarcane molasses extract contents: 1 mg / mL, 3 mg / mL, 5 mg / mL, 7 mg / mL, and 9 mg / mL. A control group without hydrogel was set up for cell culture experiments. Human umbilical vein endothelial cells (HUVECs) were co-cultured in Transwell chambers. After seeding cells in the wells, the Transwell chambers were closed, and 200 μL of the hydrogel prepared with the precursor solution was placed in the chamber, followed by 800 μL of culture medium. All six groups of cells were co-cultured in a constant temperature incubator at 37°C with 5% CO2. Cell proliferation was detected using a CCK-8 assay kit on days 1, 2, and 3 of culture. The hydrogels were co-cultured with HUVECs, with the control group without hydrogel. The experimental groups were treated as described above. Morphological analysis of dead / live cells was performed on days 1 and 3, and live / dead cell fluorescence images were captured. The results are as follows. Figure 8 and Figure 9 As shown.
[0176] Depend on Figure 8The cell viability statistics show that when the sugarcane molasses extract content in the hydrogel reaches 7 mg / mL, the cell viability still reaches 85.3% after 3 days of co-culturing with the hydrogel. This indicates that the sugarcane molasses extract, when encapsulated in hydrogel, can achieve a concentration as high as 7 mg / mL without almost any cytotoxicity. In contrast, pure sugarcane molasses extract exhibits toxic side effects on cells at concentrations of 1.5 mg / mL or higher. Therefore, the hydrogel of this invention can effectively improve the effective concentration of sugarcane molasses extract for use. Figure 9 Live / dead staining images showed that most HUVECs in each group of hydrogel samples exhibited normal morphology.
[0177] Example 3: In vitro release test of thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract
[0178] A hydrogel (Gel / OSA-DA / SME-0.7% hydrogel) with a sugarcane molasses extract concentration of 7 mg / mL was placed in a 15 mL centrifuge tube containing 5 mL of PBS and incubated at 37°C in a shaker. After a certain period, the release solution was collected, and the hydrogel was simultaneously transferred to a brand new centrifuge tube and placed under the same conditions. The absorbance of the collected release solution was measured at a wavelength of 290 nm, and the extract concentration at different time points was calculated based on a standard curve showing the change in sugarcane molasses extract content with absorbance. Figure 10 As shown, the sugarcane molasses extract of the present invention can achieve steady, slow and continuous release within 48 hours in a hydrogel.
[0179] The results above show that the hydrogel prepared by the present invention has the effect of slowly releasing sugarcane molasses extract, thus having a long-lasting effect. At the same time, it can effectively reduce the cytotoxic side effects caused by excessive concentration of sugarcane molasses extract, and greatly improve the effective concentration of sugarcane molasses extract.
[0180] Example 4: Temperature-responsive rheological properties of thermosensitive sustained-release hydrogels loaded with sugarcane molasses extract
[0181] The preparation of the thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract was the same as in Example 2. Temperature scanning was performed on the hydrogel (Gel / OSA-DA / SME-0.7%) with a sugarcane molasses extract content of 7 mg / mL using a rotational rheometer to evaluate its temperature response. Hydrogel samples (10 mm in diameter, 1 mm thick) were placed between 20 mm parallel plates, and temperature scanning tests were conducted from 0 to 50.5 °C at a constant strain of 1%, a constant frequency of 10 rad / s, and a heating rate of 3 °C / min. Changes in the storage modulus (G') and loss modulus (G”) of the hydrogel were recorded to study its temperature response. The test results are as follows: Figure 11As shown, the upper limit critical dissolution temperature (UCST) of 20% (w / v) gelatin is 33.7℃, while the thermal stability of Gel / OSA-DA / SME-0.7% increases to 37.7℃. These results show that the hydrogel prepared by this invention overcomes the shortcomings of poor thermal stability of traditional gels. More importantly, its upper limit critical dissolution temperature is near human body temperature, which allows the gel of this invention to maintain a good gel state when administered to the wound, rather than becoming a liquid and flowing away. The semi-fluid, semi-solid state provides a basis for its temperature-responsive release, which can greatly promote the sustained release of sugarcane molasses extract in the gel at the wound site.
[0182] Example 5: Antioxidant performance test of thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract
[0183] The preparation of the thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract was the same as in Example 2. The prepared hydrogels with sugarcane molasses extract contents of 3 mg / mL, 5 mg / mL, and 7 mg / mL were freeze-dried and ground into powder. The antioxidant properties of the hydrogels were detected using a DPPH and ABTS free radical assay kit. The DPPH and ABTS working solutions containing the hydrogels were sonicated at 37°C in the dark for 30 min, centrifuged for 5 min (1000 rpm), and 100 μL of the supernatant was transferred to a 96-well plate. The plate was placed in a microplate reader, and the absorbance at λ = 515 nm (DPPH) and λ = 405 nm (ABTS) was measured. The DPPH and ABTS free radical scavenging rates of the samples were calculated. The results are shown below. Figure 12 , Figure 13 As shown, the three groups of experimental hydrogels all achieved a scavenging rate of over 97% for DPPH and ABTS free radicals. The thermosensitive sustained-release hydrogel prepared in this invention can achieve excellent antioxidant effects even at relatively low concentrations of sugarcane molasses extract.
[0184] Meanwhile, the ability of thermosensitive sustained-release hydrogels loaded with sugarcane molasses extract at concentrations of 5 mg / mL and 7 mg / mL to scavenge reactive oxygen species in human umbilical vein endothelial cells was evaluated using the DCFH-DA kit. DCFH-DA (green) and DAPI (blue) staining were performed, and the results are as follows: Figure 14 As shown, the green fluorescence intensity darkened after adding a thermosensitive sustained-release hydrogel containing a certain concentration of sugarcane molasses extract. Thermosensitive sustained-release hydrogels with different extract contents all significantly reduced the green fluorescence intensity, approaching that of the negative control group without hydrogen peroxide stimulation. These results demonstrate that the thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract of this invention has an excellent ability to reduce intracellular reactive oxygen species (ROS) levels, protecting cells from excessive ROS damage and thus effectively promoting wound healing.
[0185] Example 6: In vitro antibacterial test of thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract
[0186] The preparation of the thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract was the same as in Example 2. The antibacterial effect of the thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract was evaluated using the antibacterial curve method. The content of sugarcane molasses extract in the hydrogel was adjusted to obtain two hydrogels with different sugarcane molasses extract contents of 5 mg / mL and 7 mg / mL. The above groups were then... Sterile cylindrical hydrogels were placed in 24-well plates. Finally, a bacterial suspension of Gram-negative *Escherichia coli* (E. coli) and Gram-positive *Staphylococcus aureus* (S. aureus) was added to bring the final bacterial concentration in the broth to 10-1. 4 CFU / mL, with an equal volume of bacterial broth suspension (excluding hydrogel) as the control group and an equal volume of broth suspension (excluding both bacteria and hydrogel) as the blank group, both were incubated in a constant temperature shaker at 37℃ for the corresponding time points. 100 μL of bacterial suspension from each experimental group was then placed in a 96-well plate, and the absorbance (A) of the bacterial suspension at 600 nm was measured using a microplate reader. 600 The inhibition rate of sugarcane molasses extract against Escherichia coli and Staphylococcus aureus was calculated.
[0187] like Figure 15 As shown, the thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract of the present invention exhibits a significant inhibitory effect on the growth of Escherichia coli and Staphylococcus aureus; and the antibacterial effect gradually increases with the extension of the hydrogel release time. These results demonstrate that the thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract of the present invention possesses significant antibacterial properties.
[0188] Example 7: Application of thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract in diabetic wounds
[0189] Twelve male (8-10 weeks old) diabetic rats were anesthetized by intraperitoneal injection of 1% sodium pentobarbital (30 mg / kg). The fur on the backs of the rats was shaved off and the backs were cleaned with 75% ethanol. Four circular full-thickness skin wounds were created on the backs of the rats at the same locations using a mold. Rats with successfully induced wounds were randomly divided into three groups: a, b, and c. Group a received a hydrogel prepared by blending simple gelatin with dopamine-grafted oxidized alginate; group b received a commercially available gel that had been successfully used clinically; and group c received a thermosensitive sustained-release hydrogel (Gel / OSA-DA / SME-0.7%) with a sugarcane molasses extract content of 7 mg / mL, prepared in Example 2. Dressings were changed every two days, and wound healing was monitored as follows. Figure 16As shown in the figure, the thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract of the present invention can effectively balance biocompatibility, anti-oxidation, anti-inflammation, antibacterial, angiogenesis promotion, and glycemic index reduction, thereby improving cell vitality and promoting cell proliferation from multiple aspects and at a deeper level, achieving the goal of rapid wound healing. Its effect is more significant than that of commercial gels.
[0190] The above embodiments are preferred embodiments of the present invention, but the embodiments of the present invention are not limited to the above embodiments. Any changes, modifications, substitutions, combinations, or simplifications made without departing from the spirit and principle of the present invention shall be considered equivalent substitutions and shall be included within the protection scope of the present invention.
Claims
1. A thermosensitive sustained-release hydrogel loaded with sugarcane molasses extract, characterized in that... Specifically, the preparation involves the following raw materials: sodium alginate and sodium periodate are mixed in a molar ratio of 1:1 and reacted for 9-10 hours. The reaction is terminated with ethylene glycol, and the mixture is dialyzed and freeze-dried to obtain oxidized alginic acid. Oxidized alginic acid is then blended with N-hydroxysuccinimide in a ratio of 2:2:2:
1. The pH of the reaction solution is adjusted to 4.5-4.7, and the mixture is sealed and stirred under nitrogen protection for 1-24 hours. The mixture is then dialyzed and freeze-dried under a weakly acidic environment to obtain dopamine-grafted oxidized alginic acid. Dopamine-grafted oxidized alginic acid is added to a 20% w / v gelatin solution at a mass-volume ratio of 20%. Sugarcane molasses extract powder is added and stirred until homogeneous. The mixture is then allowed to stand at 4°C to form a gel. The sugarcane molasses extract content in the gel is 1 mg / mL-9 mg / mL.
2. The application of the thermosensitive sustained-release hydrogel according to claim 1 in the preparation of chronic wound healing drugs, medical dressings for promoting chronic and difficult-to-heal wounds, and tissue regeneration drugs or dressings.
Citation Information
Patent Citations
Use of polyphenol containing sugar cane extracts for preventing, improving or treating a skin condition
CN111194219A
Preparation method of degradable antibacterial hemostatic hydrogel for promoting diabetes wound repair
CN114404648A
Natural polysaccharide-based chemical-physical double-crosslinking hydrogel particle as well as preparation and application thereof
CN115337272A
